Investigation shows genetic variants and oxidative-immune biomarkers predict disease severity in rheumatoid arthritis, suggesting clearer management strategies.
Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by persistent synovial inflammation and oxidative stress (OS). This study investigated whether pre-miRNA-499a (rs3746444) and pre-miRNA-146a (rs2910164) polymorphisms are associated with RA susceptibility and disease severity, and evaluated OS/antioxidant and inflammatory profiles in relation to disease activity score 28 based on erythrocyte sedimentation rate (DAS28‑ESR) and anti–cyclic citrullinated peptide (anti-CCP)in an Erbil-based cohort. Fifty RA patients and fifty healthy controls were genotyped by amplification refractory mutation system (ARMS-PCR). Serum OS and antioxidant markers, inflammatory cytokines, and trace elements were assessed, and their relationships with DAS28‑ESR and anti-CCP were analyzed. The rs3746444 TC genotype was significantly associated with increased RA risk (odds ratio (OR) = 2.708, p = 0.0209) and with higher DAS28‑ESR and anti-CCP levels (p = 0.020), whereas rs2910164 showed no significant association. RA patients demonstrated a disturbed redox balance and inflammatory activation compared with controls. Among the measured variables, interferon (IFN)-γ was the strongest predictor of both disease activity and anti-CCP titers (p < 0.001), with interleukin (IL)-10 and superoxide dismutase (SOD) showing an inverse relationship. pre-miRNA-499a rs3746444, particularly the TC genotype, is linked to RA susceptibility and greater disease severity in this population. IFN-γ, together with key antioxidant/inflammatory indicators, may support monitoring of RA activity and stratification of patients for more tailored management.
No takes yet. Share an insight, caveat, or question.
Jalal et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: